Page 230 - 《精细化工》2020年第5期

·1080· 精细化工 FINE CHEMICALS 第 37 卷

3 结论 derivatives[J]. Chinese Journal of Pesticide Science (农药学学报),
2015, 17(3): 251-256.
[7] ASAHI M, KOBAYASHI M, MATSUI H, et al. Differential
本文以 4-溴-2-甲基苯甲酸和乙烯基正丁醚为 mechanisms of action of the novel γ-aminobutyric acid receptor
起始原料经 7 步反应制备氟雷拉纳，其结构经 antagonist ectoparasiticides fluralaner (A1443) and fipronil[J]. Pest
Management Science, 2015, 71(1): 91-95.
1 13
HNMR、 CNMR 和 ESI-MS 确证，并对氟雷拉纳 [8] JIANG J (蒋洁), ZHANG Y (张莹), TANG T (唐涛), et al. Advances
进行杀虫活性测定。结果表明：氟雷拉纳室内杀虫 in the study of ionotropic GABA receptor targeted insecticide of
fluralaner[J]. Chinese Journal of Hygienic Insecticides & Equipments
效果显著，在 1.25 mg/L 剂量下对小菜蛾、黏虫的
(中华卫生杀虫药械), 2019, 25(5): 492-498.
杀虫效果依然可达到 100%，杀虫活性明显优于对照 [9] SHENG C W, JIA Z Q, WU H Z, et al. Insecticidal spectrum of
fluralaner to agricultural and sanitary pests[J]. Journal of Asia-Pacific
药剂四氯虫酰胺，兽药氟雷拉纳可作为先导化合物
Entomology, 2017, 20(4): 1213-1218.
在防治农业害虫领域进行深入研究，氟雷拉纳及异 [10] OZOE Y, ASAHI M, OZOE F, et al. The antiparasitic isoxazoline
唑啉类化合物具有较大的开发应用前景，将会被 A1443 is a potent blocker of insect ligand-gated chloride channels[J].
Biochemical and Biophysical Research Communications, 2010, 391:
更多的农药研发者们所关注。 744-749.
[11] MORLYAMA Y, MATOBA K, YAOSAKA M, et al. Method for
参考文献： producing substituted 4,4-difluoro-2-buten-1-one compound and
compound and method for producing substituted isoxazoline
[1] MITA T, KIKUCHI T, MIZUKOSHI T, et al. Isoxazoline-substituted compound: WO 2013021949[P]. 2011-08-05.
benzamide compound and noxious organism control agent: WO, [12] GARCÍA-REYNAGA P, ZHAO Chunqing, SARPONG R, et al. New
2005085216[P]. 2005-03-04.
[2] WEI Q (魏琪), WU S F (吴顺凡), GAO C F (高聪芬). Advances in GABA/Glutamate receptor target for [3H] isoxazoline insecticide[J].
the molecular target for insecticides of ionotropic γ-aminobutyric Chemical Research in Toxicology, 2013, 26(4): 514-516.
acid receptors[J]. Agrochemicals (农药), 2014, 53(12): 859-863, 899. [13] KAGAMI, TAKAHIRO. Insecticdal, miticidal, nematicidal, molluscicidal,
[3] ZHENG X J (郑小娇), LI H G (李华光), LIU G Y (刘根炎), et al. microbicidal, or bactericidal composition and method for controlling
Research progress of insect γ-aminobutyric acid receptor competitive pest: WO2016002790[P]. 2014-06-30.
antagonists[J]. Chinese Journal of Pesticide Science (农药学学报), [14] YAOSAKA, MANABU, UTSUNOMIYA, et al. Method for production
2017, 19(6): 665-671. of 3-hydroxypropan-1-one compound, method for production of
[4] GASSEL M, WOLF C, NOACK S, et al. The novel isoxazoline 2-propen-1-one compound, and method for production of isoxazoline
ectoparasiticide fluralaner: Selective inhibition of arthropod compound: EP2172462[P]. 2010-12-15.
γ-aminobutyric acid and L-glutamate-gated chloride channels and [15] KOUSAKA, HIROYUKI, FUKUYA, et al. Process for production of
insecticidal/acaricidal activity[J]. Insect Biochemistry and Molecular isoxazoline-substituted benzoic caid amide compound: EP2308857[P].
Biology, 2014, 45: 111-124. 2016-04-27.
[5] LING H (凌汉), LI C (李创), TANG T (唐涛), et al. Activity of [16] HUANG D Y (黄道友). Study on the synthetic technology of new
fluralaner with three insecticides and joint action of their mixtures veterinarydrug fluralaner[D]. Wuhan: Hubei University of Technology
against laodelphax striatellus[J]. Journal of Environmental (湖北工业大学), 2017.
Entomology (环境昆虫学报), 2019, 41(4): 875-881. [17] LI Q (李强), GU D Y (古冬云), LI L W (李立威), et al. Method for
[6] ZHAO C Q (赵春青), HAN Z J (韩召军), TANG T (唐涛). Research preparing 2-amino-N-(2,2,2-trifluoroethyl) acetamide: CN107353222A[P].
progress on bioeffect and toxicology of insecticide fluralaner and its 2017-11-17.

（上接第 1074 页） [9] HERMAN G A, BERGMAN A, LIU F, et al. Pharmacokinetics and
pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in
[3] ROSENSTOCK J, BRAZG R, ANDRYUK P J, et al. Efficacy and middle-aged obese subjects[J]. Journal of Clinical Pharmacology, 2006,
safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to 46(8): 876-886.
ongoing pioglitazone therapy in patients with type 2 diabetes: A [10] MU J, PETROV A, EIERMANN G J, et al. Inhibition of DPP-4 with
24-week, multicenter, randomized, double-blind, placebo-controlled, sitagliptin improves glycemic control and restores islet cell mass and
parallel-group study[J]. Clinical Herapeutics, 2006, 28(10): 1556-1568. function in a rodent model of type 2 diabetes[J]. European Journal of
[4] PRATLEY R E, NAUCK M, BAILEY T, et al. Liraglutide versus Pharmacology, 2009, 623(1/2/3): 148-154.
sitagliptin for patients with type 2 diabetes who did not have adequate [11] DESAI A A. Sitagliptin manufacture: A compelling tale of green
glycaemic control with metformin: A 26-week, randomised, parallel- chemistry, process intensification, and industrial asymmetric catalysis[J].
group, open-label trial[J]. The Lancet, 2010, 375(9724): 1447-1456. Angewandte Chemie International Edition, 2011, 50(9): 1974-1976.
[5] MA Yuanyuan (马圆圆), WANG Song (王松). Effects of sitagliptin [12] HANSEN K B, HSIAO Y, XU F et al. Highly efficient asymmetric
on serum paraoxonase and oxidative stress in patients with type 2 synthesis of sitagliptin[J]. Journal of the American Chemical Society,
diabetes[J]. Journal of practical diabetes (实用糖尿病杂志), 2019, 2009,131(25): 8798-8804.
15(5): 12. [13] MOWAKA S, MOHAMED D. Novel contribution to the simultaneous
[6] LI Jinyan (李金燕). Cardioprotective effect of sitagliptin on type 2 analysis of certain hypoglycemic drugs in the presence of their
diabetes patients[J]. Capital Food and Medicine (首都食品与医药), impurities and degradation products utilizing UPLC-MS/MS[J]. RSC
2019, 26(20): 52. Advances, 2015, 5(74): 60467-60481.
[7] HUANG Huanxian (黄焕贤), DENG Xiujuan (邓秀娟). Clinical [14] SONUNE D P, MONE M K. Isolation, characterization of
observation of sitagliptin in the treatment of type 2 diabetes with degradation products of sitagliptin and development of validated
non-alcoholic fatty liver disease[J]. Capital Food and Medicine, stability-indicating HPLC assay method for sitagliptin API and
2019, 26(16): 46-47. tablets[J]. International Journal of Pharmaceutical Sciences and
[8] SHI Xiaojuan (石晓娟). Therapeutic effect of T 2DM sitagliptin on Research, 2013, 4(9): 3494-3503.
newly diagnosed elderly patients with type 2 diabetes and its effect [15] METIL D S, SAMPATH A, REDDY J R, et al. Efficient and
on blood pressure[J]. Journal of Practical Diabetes (实用糖尿病杂 convenient synthetic routes for sitagliptin impurities[J]. Chemistry
志), 2019, 15(4): 17-18. Select, 2018, 3(10): 2723-2729.